Vistagen Therapeutics, Inc. (VTGN)

Vistagen Therapeutics Revenue

Vistagen Therapeutics had revenue of $244.00K in the quarter ending June 30, 2025, with 190.48% growth. This brings the company's revenue in the last twelve months to $646.00K, down -33.47% year-over-year. In the fiscal year ending March 31, 2025, Vistagen Therapeutics had annual revenue of $486.00K, down -54.32%.

• Revenue (ttm): $646.00K
• Revenue Growth: -33.47%
• P/S Ratio: 141.55
• Revenue / Employee: $11,333
• Employees: 57
• Market Cap: 89.89M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2025	486.00K	-578.00K	-54.32%
Mar 31, 2024	1.06M	1.29M	-568.72%
Mar 31, 2023	-227.00K	-1.34M	-120.47%
Mar 31, 2022	1.11M	19.40K	1.78%
Mar 31, 2021	1.09M	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.